Challenges Medical Oncologists Will Face Due To Health Care Reform
Debra Patt, MD, MPH, MBA, medical oncologist, director of Public Policy, Texas Oncology, director of Health Care Informatics, McKesson Specialty Health and The US Oncology Network, discusses the challenges that medical oncologists will face due to health care reform.
Patt mentions that there are several challenges with the work force. When they begin working with the alternative payment model, Patt says they will need data, which has never been delivered before. This will allow Patt and her team to report how they are doing with the model, in terms of quality of care and outcomes.
Debra Patt, MD, MPH, MBA, medical oncologist, director of Public Policy, Texas Oncology, director of Health Care Informatics, McKesson Specialty Health and The US Oncology Network, discusses the challenges that medical oncologists will face due to health care reform.
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More
